This randomised controlled trial ( DATA-Switch ) is a preplanned extension of the denosumab and teriparatide administration study ( DATA ) , in which @ postmenopausal osteoporotic women were randomly assigned to receive @ months of teriparatide ( @ mg daily ) , denosumab ( @ mg every @ months ) , or both drugs .